Tekla Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $30.5K | Hold |
7,520
| – | – | ﹤0.01% | 164 |
|
|
2023
Q1 | $23.2K | Sell |
7,520
-2
| -0% | -$6 | ﹤0.01% | 175 |
|
|
2022
Q4 | $20.3K | Hold |
7,522
| – | – | ﹤0.01% | 168 |
|
|
2022
Q3 | $30K | Hold |
7,522
| – | – | ﹤0.01% | 164 |
|
|
2022
Q2 | $53K | Hold |
7,522
| – | – | ﹤0.01% | 173 |
|
|
2022
Q1 | $88K | Hold |
7,522
| – | – | ﹤0.01% | 170 |
|
|
2021
Q4 | $138K | Hold |
7,522
| – | – | ﹤0.01% | 166 |
|
|
2021
Q3 | $188K | Hold |
7,522
| – | – | 0.01% | 168 |
|
|
2021
Q2 | $475K | Hold |
7,522
| – | – | 0.02% | 182 |
|
|
2021
Q1 | $927K | Hold |
7,522
| – | – | 0.03% | 178 |
|
|
2020
Q4 | $856K | Hold |
7,522
| – | – | 0.03% | 185 |
|
|
2020
Q3 | $899K | Hold |
7,522
| – | – | 0.03% | 183 |
|
|
2020
Q2 | $937K | Buy |
7,522
+5,047
| +204% | +$629K | 0.04% | 195 |
|
|
2020
Q1 | $478K | Buy |
+2,475
| New | +$478K | 0.02% | 198 |
|
|
2018
Q4 | – | Sell |
-344
| Closed | -$244K | – | 211 |
|
|
2018
Q3 | $244K | Buy |
+344
| New | +$244K | 0.01% | 207 |
|